Form 4: Pacific Biosciences Director Exercises Stock Options

Director Marshall Mohr exercised stock options to acquire 25,000 shares of Pacific Biosciences common stock at a price of $4.45 on March 1, 2024.

Summary

• On March 1, 2024, Marshall Mohr, a director of Pacific Biosciences of California, Inc., exercised stock options.
• This transaction involved the acquisition of 25,000 shares of common stock at a price of $4.45 per share.
• Following the transaction, Mohr directly owns 110,000 shares of Pacific Biosciences common stock.
• The stock options exercised were fully vested and exercisable as of the transaction date, with an expiration date of May 22, 2024.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of an insider transaction.

Industry Context

This is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors.

Stakeholder Impact

• The transaction may have a minor impact on shareholders due to the increase in outstanding shares, but it's unlikely to be significant.

Key Dates